Key Comparative Indicator May Reflect Positive Potential for Continued Strong and Upward Trend of Cryo-Cell’s Stock Performance
Amplify’d from cryo-cell.com
Oldsmar, FL – June 21, 2011 – Cryo-Cell International, Inc. (OTCQX: CCEL) (the “Company”), one of the world’s largest and most established family cord blood banks and global industry leader in innovative stem cell solutions, announced today that it was evaluated by SmarTrend as among five companies in the Health Care Services industry with the lowest P/E ratios. According to SmarTrend, P/E is an important valuation tool when comparing companies in the same industry. A higher P/E ratio means that investors are paying more for each unit of net income, so the stock is more expensive compared to one with a lower P/E ratio. Cryo-Cell International has the lowest with a P/E of 7.0x. An article with SmarTrend’s analysis can be found at http://www.mysmartrend.com/news-briefs/news-watch/relatively-low-pe-ratio-health-care-services-industry-detected-shares-cryo-ce
See this Amp at http://bit.ly/jbXbVH
No comments:
Post a Comment